Cath Lab

September 12, 2014 — Volcano Corp. announced it will be launching its interventional precision guidance tools at the 27th annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium, being held in Washington, D.C., Sept. 13-17.

Medtronic Inc. announced the first U.S. implants in the CoreValve Evolut R Clinical Study, which will evaluate  the safety and effectiveness of the new Medtronic CoreValve Evolut R System.

TCT 2014, late breaking trials, late breaking presentations

Transcatheter Cardiovascular Therapeutics (TCT) has announced the late-breaking trial presentations at TCT 2014, Sept. 13-17.

September 4, 2014 — Medtronic announced CE mark for the 23 mm CoreValve Evolut R system for transcatheter aortic valve implantation (TAVI). The novel self-expanding valve and 14 French equivalent delivery system offers new capabilities that advanc...

PARTNER I Trial TCT 2014 TAVR Heart Valve Repair
New data from a landmark clinical trial found that after five years, transcatheter aortic valve replacement (TAVR) demonstrated a persistent mortality benefit...
A new study found that fractional flow reserve (FFR)-guided provisional side branch (SB) stenting of true coronary bifurcation lesions yields similar outcomes...
September 17, 2014 — A new clinical trial found that vascular closure devices (VCDs) are non-inferior to manual compression in patients undergoing transfemoral...
September 17, 2014 — GE Healthcare announced it has installed its Cath Lab Efficiency Manager at Saint Luke’s Mid America Heart Institute in Kansas City, Mo....
GE Healthcare's Cath Lab Efficiency Manager is a new analytical tool that analyzes the performance of an interventional lab, providing
Ecolab Healthcare's PD220 patient drape is the first to market specifically for Boston Scientific’s subcutaneous implantable cardioverter-...
Medtronic's NC Euphora noncompliant balloon dilatation catheter was 510(k) cleared by the U.S. Food and Drug Administration (FDA) in...
Esaote North America's MyLab Six ultrasound system is 510(k)-cleared from the U.S. Food and Drug Administration (FDA) and available for...

Articles

September 17, 2014 — A new clinical trial found that vascular closure devices (VCDs) are non-inferior to manual compression in patients undergoing transfemoral...
Medtronic U.S. Implants Clinical Study Recapturable CoreValve Evolut R
Medtronic Inc. announced the first U.S. implants in the CoreValve Evolut R Clinical Study, which will evaluate  the safety and effectiveness of the new...
Covidien TurboHawk Clinical Study Directional Atherectomy Effective PAD Therapy
Directional atherectomy is safe and effective as a frontline therapy for the treatment of peripheral arterial disease (PAD), according to a landmark Covidien...
September 4, 2014 — Medtronic announced CE mark for the 23 mm CoreValve Evolut R system for transcatheter aortic valve implantation (TAVI). The novel self-...

Video Center

As technology continues to advance for all diagnostic imaging modalities, it sometimes reminds me...
2 weeks 1 day ago
The Society of Cardiovascular Computed Tomography (SCCT) annual meeting July 10-13 in San Diego...
7 weeks 6 days ago
A big fly in the ointment for widespread adoption of many new technologies is cost. In today’s cost...
10 weeks 1 day ago
This webinar explained the benefits of better access, productivity and revenue cycle efficiency in a modern cardiovascular information system (CVIS...
The webinar "PET/CT: A New Frontier" discusses potential benefits of digital relative to analog PET/CT. The session will discuss how digital PET can improve...
Centricity Cardio Enterprise, Cardiac PACS, Cardio PACS, CVIS
This webinar demonstrates the Centricity Cardio Enterprise Solution (CCE), a solution that can help cardiology departments and hospital administrators to...